Seeking Alpha

Don Dion's  Instablog

Don Dion
  • on IPO Analysis
Send Message
Don Dion (, @DRDInvestments) is the owner and Chief Investment Officer of DRD Investments, LLC, based in Naples, FL. and Williamstown, MA., a family office focused on managing a long/short hedge fund, real estate assets and various other financial assets for the Dion family.... More
My company:
DRD Investments, LLC
My blog:
My book:
The Ultimate Guide to Trading ETFs
View Don Dion's Instablogs on:
  • IPO Lockup Expiration - TubeMobul (TUBE) - Wed., 1.14
    • January 14, 2015, concludes the 180-day lockup period for TUBE; at this point, TUBE's major pre-IPO shareholders will be able to sell ~22 million previously restricted shares.
    • With TUBE's IPO consisting of just ~6.3 million shares, the event could cause a supply shock and significantly decrease the price of TUBE stock.
    • TUBE has posted very strong results, and its price has nearly tripled since its IPO; insiders could be itching for profits.
    • We see the possibility for strong negative returns and a short opportunity at TUBE's lockup expiration.
    • See our full article for further analysis.
    Tags: TUBE
    Jan 12 9:37 AM | Link | Comment!
  • IPO Lockup Expiration - Globant S.A. - Wed., 1.14
    • January 14, 2015 concludes the 180-day lockup period on creative IT company Globant S.A.
    • When the lockup period ends, Globant's pre-IPO shareholders will have the chance to sell their ~26 million shares (previously restricted); this may cause a significant decrease in Globant's share price.
    • Recent research shows greatest negative returns (-5.8%) in the period of days (-11, 9) surrounding the event day (0).
    • We suggest investors consider a short opportunity in the days surrounding the event.
    • Full analysis here.
    Tags: GLOB
    Jan 12 9:35 AM | Link | Comment!
  • IPO Quiet Period Expiration: Juno Therapeutics - 1.13
    • The 25-day quiet period on JUNO ends 1/13, allowing the firm's IPO underwriters to publish recommendations on 1/14.
    • Underwriters include Goldman Sachs, J.P. Morgan, Morgan Stanley, and Leerink Partners; research has shown a correlation between underwriter quality and share price increases at the quiet period expiration.
    • JUNO has had a solid start to trading; long-term, its impressive founders, management, and research team could develop it successfully.
    • We see the current dip as a buying opportunity for this hot biotech firm in a very strong life sciences industry.
    • Full analysis here.
    Tags: JUNO
    Jan 12 8:48 AM | Link | Comment!
Full index of posts »
Latest Followers


More »

Latest Comments

Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.